Montega keeps its EUR 23.00 target for Medios stock

Published on 10/05/2026 at 11:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medios targets EUR 3.1 billion revenue by 2031, up 50.00 percent from 2025. Medios stock costs EUR 10.42 on October 5, 2026 after EUR 10.47.

Pop-Art-Comic eines Pharmazeuten, der triumphierend ein Glasfläschchen in die Höhe hält — Medios AG (DE000A1MMCC8) wird als farbenfrohe Pop-Art-Comicszene mit stolzem Pharmazeuten und Medikamentenfläschchen dargestellt, Illustration mit AI erstellt.

Medios (ISIN DE000A1MMCC8) carries a EUR 23.00 12-month target after EQS News reported Montega's Buy rating on October 2, 2026. Medios stock was trading at EUR 10.42 at Lang & Schwarz on October 5, 2026 at 11:35 a.m. CEST, giving the target a wide valuation gap for investors to assess.

Montega sees EUR 23.00 value

The Montega research update set a 12-month price target of EUR 23.00 and retained a Buy recommendation for Medios. The report followed the company's Capital Markets Day, where management presented its strategy through 2031.

wallstreetONLINE reported on October 2, 2026 that Berenberg cut its target from EUR 25.00 to EUR 22.00 while retaining a Buy rating. The bank cited pressure from lower German reimbursement rates, making the regulatory backdrop a material counterweight to the longer-term growth plan.

Revenue target reaches EUR 3.1 billion

According to Deutsche Börse, Medios presented its Ambition 2031 plan on September 29, 2026. Group revenue is targeted to rise from EUR 2.1 billion in fiscal year 2025 to EUR 3.1 billion by 2031, a 50.00 percent increase.

The plan also calls for adjusted EBITDA to double from EUR 87.0 million in fiscal year 2025 to EUR 170.0 million by 2031. Medios stated that adjusted EBITDA was EUR 87.0 million with a 4.20 percent margin in fiscal year 2025, while the 2031 target implies an adjusted EBITDA margin of 5.50 percent.

Stock remains below its yearly high

Medios stock stood at EUR 10.42 at Lang & Schwarz on October 5, 2026, versus the prior close of EUR 10.47 on October 2, 2026. The 0.48 percent decline keeps the quote 40.25 percent below the 52-week high of EUR 17.44 and 4.41 percent above the 52-week low of EUR 9.98, both reported for October 2, 2026.

Medios had a market capitalization of EUR 254.4 million on October 2, 2026. Its shares are traded on the Regulated Market of the Frankfurt Stock Exchange in the Prime Standard and are included in the SDAX, while the company operates in specialty pharmaceutical supply and compounding.

The further course of trading is shown by the continuously updated real-time quote of Medios stock.